A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

Not specified

Conditions
HIV InfectionsHistoplasmosisBlastomycosis
Interventions
DRUG

Itraconazole

DRUG

Amphotericin B

Trial Locations (9)

30303

Division of Infectious Diseases, Atlanta

35294

UAB Station / Infectious Division, Birmingham

46202

Division of Inf Diseases/ Indiana Univ Hosp, Indianapolis

46218

Community Hosp, Indianapolis

48105

Ann Arbor Veterans Administration Med Ctr, Ann Arbor

64132

Infectious Diseases Association / Research Med Ctr, Kansas City

71130

LSU Med Ctr / Div of Pulmonary & Critical Care Med, Shreveport

72205

Univ of Arkansas for Med Sciences, Little Rock

641082792

Univ of Missouri / Division of Infectious Diseases, Kansas City

All Listed Sponsors
lead

Janssen, LP

INDUSTRY

NCT00002159 - A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis | Biotech Hunter | Biotech Hunter